Therefore, the results of the two studies are not directly comparable and not necessarily discordant
We report here the hormonal, metabolic and gonadal responses to the glucagon-like peptide-1 (GLP1)-based multi-agonists, GLP1/Estrogen (GLP1/E), GLP1/gastric inhibitory peptide (GLP1/GIP) and GLP1/GIP/Glucagon, in two mouse PCOS models, with variable penetrance of metabolic and reproductive traits, and their comparison with metformin
This combination isnt just about achieving a number on the scale but about creating lasting changes in body composition that support lifelong health and wellness
This value was used to calculate (tau/Ka) values through normalization of the transduction coefficient (tau/Ka) for each ligand in each signalling pathway to the reference ligand (hGLP1 in black) and the reference signalling pathway (cAMP)
it changes exposure, safety, and evidence interpretation
What to Expect: Timeline of Results Understanding realistic timelines prevents disappointment and helps identify when peptides are or are not working as expected
